Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron vs naloxone for intrathecal opioid-induced pruritus after spinal anesthesia
IRCT20250306064951N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Sep 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in pruritus and None comparing Ondansetron with Naloxone (2 arms). Primary endpoint: Improvement of pruritus severity. Started Sep 2025; status: completed.
02
Drugs
ondansetronnaloxone
03
Conditions
pruritus
Beyond the preview
Go deeper on IRCT20250306064951N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250306064951N1.